- 1H25 results were within expectations. Revenue and adj. PATMI were 47% and 40%, respectively, of our FY25e forecast. Adj. PATMI expanded 4.7% y-o-y to S$8.3mil. Q&M Dental reported a S$4.3mil loss from consolidating Aoxin and EM2AI from an associate. Core dental revenue rose 4% y-o-y to S$87.4mil but offset by S$3mil from cessation of the lab business in Sep24.
- - Read this at SGinvestors.io -
- Q&M Dental opened eight and closed four clinics in Singapore over the past 12 months.
The Positive
Most stable cost.
- - Read this at SGinvestors.io -
- As revenue recovers, there is room for higher operating leverage.
The Negative
Shrinking clinics in Malaysia.
- Read more at SGinvestors.io.
Above is an excerpt from a report by Phillip Securities Research.
Clients of Phillip Capital may be the first to access the full PDF report @ https://www.stocksbnb.com/.
Paul Chew Phillip Securities Research | https://www.poems.com.sg/ 2025-08-20
Read also Phillip's most recent report:
2026-03-25 Q&M Dental - Establishing An Asia-pacific Dental Franchise.
Price targets by 2 other brokers at Q&M Dental Target Prices.
Listing of research reports at Q&M Dental Analyst Reports.
Relevant links:
Q&M Dental Share Price History,
Q&M Dental Announcements,
Q&M Dental Dividend Payout Dates & Corporate Actions,
Q&M Dental News
